论文标题
诊断帕金森氏病的机器学习:系统评价
Machine learning for the diagnosis of Parkinson's disease: A systematic review
论文作者
论文摘要
帕金森氏病(PD)的诊断通常是基于医学观察结果和评估临床体征,包括表征多种运动症状。但是,传统的诊断方法可能会遭受主观性的影响,因为它们依靠对人眼有时微妙而又难以分类的运动的评估,从而导致可能的错误分类。同时,PD的早期非运动症状可能是温和的,可能是许多其他情况引起的。因此,这些症状经常被忽略,从而使PD在早期具有挑战性。为了解决这些困难并完善PD的诊断和评估程序,已经实施了机器学习方法来分类PD和健康对照,或具有相似临床表现的患者(例如,运动障碍或其他帕金森综合症)。为了全面概述在PD诊断和鉴别诊断中使用的数据模式和机器学习方法,在这项研究中,我们使用PubMed和IEEE Xplore数据库进行了直到2020年2月14日发表的研究的系统文献综述。总共包括209项研究,提取以获取相关信息,并在本系统的综述中介绍,并研究了其目的,数据源,数据类型,机器学习方法和相关结果。这些研究表明,在临床决策中适应机器学习方法和新型生物标志物具有很高的潜力,从而导致对PD的系统性越来越有系统的诊断。
Diagnosis of Parkinson's disease (PD) is commonly based on medical observations and assessment of clinical signs, including the characterization of a variety of motor symptoms. However, traditional diagnostic approaches may suffer from subjectivity as they rely on the evaluation of movements that are sometimes subtle to human eyes and therefore difficult to classify, leading to possible misclassification. In the meantime, early non-motor symptoms of PD may be mild and can be caused by many other conditions. Therefore, these symptoms are often overlooked, making diagnosis of PD at an early stage challenging. To address these difficulties and to refine the diagnosis and assessment procedures of PD, machine learning methods have been implemented for the classification of PD and healthy controls or patients with similar clinical presentations (e.g., movement disorders or other Parkinsonian syndromes). To provide a comprehensive overview of data modalities and machine learning methods that have been used in the diagnosis and differential diagnosis of PD, in this study, we conducted a systematic literature review of studies published until February 14, 2020, using the PubMed and IEEE Xplore databases. A total of 209 studies were included, extracted for relevant information and presented in this systematic review, with an investigation of their aims, sources of data, types of data, machine learning methods and associated outcomes. These studies demonstrate a high potential for adaptation of machine learning methods and novel biomarkers in clinical decision making, leading to increasingly systematic, informed diagnosis of PD.